P.Y. Yu - Concepedia

Author

P.Y. Yu

First Affiliated Hospital of Guangzhou Medical University ORCID

Also Known As

Junyan Zhang, P.Y. Yu, Peng-Jiu Yu, Pengjiu Yu, Pingle Yu, Pingmei Yu, Yu Peng-Jiu

Publications

513

Citations

H-Index

Concepts

All Affiliations

First Affiliated Hospital of Guangzhou Medical University Guangzhou Medical University Southern Medical University First Affiliated Hospital of Guangdong Pharmaceutical University

About

P.Y. Yu is an author at First Affiliated Hospital of Guangzhou Medical University specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	351
2	Allergy	2	2	117
3	Biochemistry	2	2	69
4	Engineering	1	1	12
5	Public Health	1	1	12

P.Y. Yu

Publications

467

Citations

H-Index

Page 1

	Year	Citations
Anti-inflammatory and Anti-oxidative Effects of Dexpanthenol on Lipopolysaccharide Induced Acute Lung Injury in Mice Limei Wan, Tan Hong Jie, Shanhe Wan, Inflammation Acute Lung InjuryInflammationAnti-oxidative EffectsAnti-inflammatoryInflammatory Lung Disease	2016	62
Pyranocoumarins Isolated from Peucedanum praeruptorum Dunn Suppress Lipopolysaccharide-Induced Inflammatory Response in Murine Macrophages Through Inhibition of NF-κB and STAT3 Activation P.Y. Yu, Hong Jin, Jun-Yan Zhang, Inflammation InflammationAnti-inflammatoryMedicineImmunologyStat3 Activation	2011	61
Preventive and Therapeutic Effects of Thymol in a Lipopolysaccharide-Induced Acute Lung Injury Mice Model Limei Wan, Dong-Mei Meng, Hong Wang, Inflammation Acute Lung InjuryInflammationAllergyInflammatory Lung DiseaseRespiratory Toxicology	2017	55
Mollugin Inhibits the Inflammatory Response in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Blocking the Janus Kinase-Signal Transducers and Activators of Transcription Signaling Pathway Zhengguang Zhu, Hong Jin, P.Y. Yu, Biological and Pharmaceutical Bulletin ImmunologyJak2 InhibitorInnate ImmunityOxidative StressInflammation	2013	54
Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8/FOXA1 signals Shao Wu, Zhi Luo, P.Y. Yu, Biological Chemistry	2015	52
FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells Yuwen He, Hui Xie, P.Y. Yu, Cancer Chemotherapy and Pharmacology Cisplatin ResistanceOncologyMedicineEpithelial–mesenchymal TransitionCancer Cell Biology	2018	52
Praeruptorin D and E attenuate lipopolysaccharide/hydrochloric acid induced acute lung injury in mice P.Y. Yu, Jing‐Rong Li, Zhengguang Zhu, European Journal of Pharmacology InflammationAcute Lung InjuryLipopolysaccharide/hydrochloric AcidInflammatory Lung DiseaseLung Inflammation	2013	36
Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149 Yuwen He, Danyang Chen, Yanmei Yi, Molecular Therapy — Oncolytics	2020	28
Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluation Hui Xie, Shaogao Zeng, Yuwen He, European Journal of Medicinal Chemistry Novel Dpp-4 InhibitorMedicineRational Drug DesignSar StudyRapid Generation	2017	16
Methyl-1-hydroxy-2-naphthoate, a novel naphthol derivative, inhibits lipopolysaccharide-induced inflammatory response in macrophages via suppression of NF-κB, JNK and p38 MAPK pathways Junyan Zhang, Hong Jin, Guangfa Wang, Inflammation Research InflammationAnti-inflammatoryBiochemistryMedicineNovel Naphthol Derivative	2011	15

Page 1